• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他克莫司诱导的β细胞功能障碍:解释 2 型糖尿病的一种方式?

Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?

机构信息

Research Unit, Hospital Universitario de Canarias, 38320 La Laguna, Santa Cruz de Tenerife, Spain.

Fundación General de la Universidad, Universidad de La Laguna, 38204 La Laguna, Santa Cruz de Tenerife, Spain.

出版信息

Int J Mol Sci. 2021 Sep 24;22(19):10311. doi: 10.3390/ijms221910311.

DOI:10.3390/ijms221910311
PMID:34638652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8509035/
Abstract

The combination of insulin resistance and β-cells dysfunction leads to the onset of type-2 diabetes mellitus (T2DM). This process can last for decades, as β-cells are able to compensate the demand for insulin and maintain normoglycemia. Understanding the adaptive capacity of β-cells during this process and the causes of its failure is essential to the limit onset of diabetes. Post-transplant diabetes mellitus (PTDM) is a common and serious disease that affects 30% of renal transplant recipients. With the exception of immunosuppressive therapy, the risk factors for T2D are the same as for PTDM: obesity, dyslipidaemia, insulin resistance and metabolic syndrome. Tacrolimus (TAC) is the immunosuppressant of choice after renal transplantation but it has the highest rates of PTDM. Our group has shown that insulin resistance and glucolipotoxicity, without favouring the appearance of apoptosis, modify key nuclear factors for the maintenance of identity and functionality of β-cells. In this context, TAC accelerates or enhances these changes. Our hypothesis is that the pathways that are affected in the progression from pre-diabetes to diabetes in the general population are the same pathways that are affected by TAC. So, TAC can be considered a tool to study the pathogenesis of T2DM. Here, we review the common pathways of β-cells dysfunction on T2DM and TAC-induced diabetes.

摘要

胰岛素抵抗和β细胞功能障碍的结合导致 2 型糖尿病(T2DM)的发生。这个过程可以持续几十年,因为β细胞能够补偿胰岛素的需求并维持正常血糖水平。了解β细胞在此过程中的适应能力及其衰竭的原因对于限制糖尿病的发生至关重要。移植后糖尿病(PTDM)是一种常见且严重的疾病,影响 30%的肾移植受者。除免疫抑制治疗外,T2D 的危险因素与 PTDM 相同:肥胖、血脂异常、胰岛素抵抗和代谢综合征。他克莫司(TAC)是肾移植后的首选免疫抑制剂,但它导致 PTDM 的发生率最高。我们的研究小组已经表明,胰岛素抵抗和糖脂毒性不会促进细胞凋亡,但会改变β细胞维持其特性和功能的关键核因子。在这种情况下,TAC 会加速或增强这些变化。我们的假设是,在一般人群中从糖尿病前期进展到糖尿病的过程中受影响的途径与 TAC 受影响的途径相同。因此,TAC 可以被视为研究 T2DM 发病机制的工具。在这里,我们回顾了 T2DM 和 TAC 诱导的糖尿病中β细胞功能障碍的常见途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/8509035/b892d895da09/ijms-22-10311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/8509035/e599a558a65a/ijms-22-10311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/8509035/b892d895da09/ijms-22-10311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/8509035/e599a558a65a/ijms-22-10311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/8509035/b892d895da09/ijms-22-10311-g003.jpg

相似文献

1
Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?他克莫司诱导的β细胞功能障碍:解释 2 型糖尿病的一种方式?
Int J Mol Sci. 2021 Sep 24;22(19):10311. doi: 10.3390/ijms221910311.
2
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.解析他克莫司诱导的胰岛β细胞毒性。
Am J Transplant. 2017 Nov;17(11):2829-2840. doi: 10.1111/ajt.14323. Epub 2017 Jun 1.
3
Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.稳定肾移植受者从每日两次他克莫司转换为每日一次缓释他克莫司后的β细胞功能和胰岛素抵抗
Ann Transplant. 2016 Dec 16;21:765-774. doi: 10.12659/aot.900638.
4
No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure.在接受他克莫司治疗 12 年后,肾移植受者的刺激胰岛素分泌没有进行性恶化的证据。
J Diabetes Complications. 2017 Sep;31(9):1384-1388. doi: 10.1016/j.jdiacomp.2017.07.001. Epub 2017 Jul 4.
5
Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome.他克莫司在肥胖和代谢综合征表型模型中诱导糖尿病。
Front Endocrinol (Lausanne). 2024 Apr 29;15:1388361. doi: 10.3389/fendo.2024.1388361. eCollection 2024.
6
Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.他克莫司的使用与移植后糖尿病的发生:一项巴西单中心观察性研究。
Transplant Proc. 2010 Mar;42(2):475-8. doi: 10.1016/j.transproceed.2010.02.021.
7
Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update.肾移植受者的移植后糖尿病和糖尿病前期:最新进展。
Nephron. 2021;145(4):317-329. doi: 10.1159/000514288. Epub 2021 Apr 26.
8
Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study.移植后 1 年内胰岛素分泌和胰岛素抵抗轨迹:一项多中心前瞻性队列研究。
Endocrinol Metab (Seoul). 2020 Dec;35(4):820-829. doi: 10.3803/EnM.2020.743. Epub 2020 Nov 18.
9
Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors.接受钙调神经磷酸酶抑制剂治疗的肾移植受者的胰岛素抵抗
Ann Transplant. 2007;12(2):26-9.
10
Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus.转录因子 7 样 2(TCF7L2)基因多态性与他克莫司治疗的肾移植患者移植后糖尿病的关系。
Pharmacol Rep. 2011;63(3):826-33. doi: 10.1016/s1734-1140(11)70595-3.

引用本文的文献

1
Rescuing vascular dysfunction in dorsal pancreatic arteries prevents tacrolimus-induced glucose metabolism disorder in mice.挽救背侧胰动脉的血管功能障碍可预防他克莫司诱导的小鼠葡萄糖代谢紊乱。
Mol Med. 2025 Jun 11;31(1):230. doi: 10.1186/s10020-025-01282-7.
2
Diabetes Mellitus in Kidney Transplant Recipients: New Horizons in Treatment.肾移植受者中的糖尿病:治疗新视野
J Clin Med. 2025 Feb 7;14(4):1048. doi: 10.3390/jcm14041048.
3
The safety of cyclosporine and tacrolimus in pediatric nephrotic syndrome patients: a disproportionate analysis based on the FAERS database.

本文引用的文献

1
Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update.肾移植受者的移植后糖尿病和糖尿病前期:最新进展。
Nephron. 2021;145(4):317-329. doi: 10.1159/000514288. Epub 2021 Apr 26.
2
Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling.通过抑制 TGF-β/Smad3 信号转导保护β细胞凋亡。
Cell Death Dis. 2020 Mar 13;11(3):184. doi: 10.1038/s41419-020-2365-8.
3
Tacrolimus-Induced BMP/SMAD Signaling Associates With Metabolic Stress-Activated FOXO1 to Trigger β-Cell Failure.他克莫司诱导的 BMP/SMAD 信号与代谢应激激活的 FOXO1 一起触发β细胞衰竭。
环孢素和他克莫司在儿童肾病综合征患者中的安全性:基于FAERS数据库的不成比例分析。
Front Pediatr. 2025 Jan 7;12:1487441. doi: 10.3389/fped.2024.1487441. eCollection 2024.
4
Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group.肾移植受者糖尿病预防、筛查及治疗的当前实践:欧洲调查中ERA DESCARTES工作组的重点内容
Clin Kidney J. 2024 Dec 10;18(1):sfae367. doi: 10.1093/ckj/sfae367. eCollection 2025 Jan.
5
Tacrolimus and diabetic rodent models.他克莫司与糖尿病啮齿动物模型。
Pharmacol Rep. 2025 Apr;77(2):333-354. doi: 10.1007/s43440-024-00693-3. Epub 2025 Jan 21.
6
Advanced therapy to cure diabetes: mission impossible is now possible?治愈糖尿病的先进疗法:“不可能完成的任务”现在有可能实现吗?
Front Cell Dev Biol. 2024 Nov 19;12:1484859. doi: 10.3389/fcell.2024.1484859. eCollection 2024.
7
Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats.肠道微生物群和代谢组学特征变化在他克莫司诱导的大鼠糖尿病中起关键作用。
Front Cell Infect Microbiol. 2024 Sep 17;14:1436477. doi: 10.3389/fcimb.2024.1436477. eCollection 2024.
8
Tacrolimus: Physicochemical stability challenges, analytical methods, and new formulations.他克莫司:物理化学稳定性挑战、分析方法及新剂型
Int J Pharm X. 2024 Sep 15;8:100285. doi: 10.1016/j.ijpx.2024.100285. eCollection 2024 Dec.
9
Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies.药物性高血糖与糖尿病:当前文献综述及实际管理策略
Diabetes Ther. 2024 Sep;15(9):2001-2025. doi: 10.1007/s13300-024-01628-0. Epub 2024 Jul 31.
10
Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome.他克莫司在肥胖和代谢综合征表型模型中诱导糖尿病。
Front Endocrinol (Lausanne). 2024 Apr 29;15:1388361. doi: 10.3389/fendo.2024.1388361. eCollection 2024.
Diabetes. 2020 Feb;69(2):193-204. doi: 10.2337/db19-0828. Epub 2019 Nov 15.
4
Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.2 型糖尿病中β细胞脂肪和糖毒性作用机制的最新研究进展。
J Mol Biol. 2020 Mar 6;432(5):1514-1534. doi: 10.1016/j.jmb.2019.09.016. Epub 2019 Oct 16.
5
Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus.抑制 mTOR 通路:他克莫司诱导β细胞毒性的新机制。
Am J Transplant. 2019 Dec;19(12):3240-3249. doi: 10.1111/ajt.15483. Epub 2019 Jul 8.
6
The Role of the TGFβ Receptor Signaling Pathway in Adult Beta Cell Proliferation.TGFβ 受体信号通路在成体胰岛β细胞增殖中的作用。
Int J Mol Sci. 2018 Oct 12;19(10):3136. doi: 10.3390/ijms19103136.
7
Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions.糖尿病中β细胞去分化的机制:最新发现和未来研究方向。
J Endocrinol. 2018 Feb;236(2):R109-R143. doi: 10.1530/JOE-17-0516. Epub 2017 Dec 4.
8
GSK3 and its interactions with the PI3K/AKT/mTOR signalling network.糖原合成酶激酶3及其与磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号网络的相互作用
Adv Biol Regul. 2017 Aug;65:5-15. doi: 10.1016/j.jbior.2017.06.003. Epub 2017 Jun 27.
9
Effects of metformin on compensatory pancreatic β-cell hyperplasia in mice fed a high-fat diet.二甲双胍对高脂饮食喂养小鼠代偿性胰腺β细胞增生的影响。
Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E367-E380. doi: 10.1152/ajpendo.00447.2016. Epub 2017 May 16.
10
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.解析他克莫司诱导的胰岛β细胞毒性。
Am J Transplant. 2017 Nov;17(11):2829-2840. doi: 10.1111/ajt.14323. Epub 2017 Jun 1.